ロード中...
Drug-excipient and drug-drug mixtures: a pathway for the production of co-amorphous entities
Introduction: Bioavailability is a milestone in drug development, since it reflects the amount of drug absorbed that reaches the site of action. About 70-90% of all drugs in R&D have problems regarding solubility in water, thus presenting low bioavailability [1]. Consequently, high doses of drug...
保存先:
| 出版年: | Ann Med |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7888847/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07853890.2018.1561802 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|